May 8, 2017 Acad, Gov/Utilities Mass Spectrometry Product Launch

AMETEK Develops FlarePro Mass Spectrometer for Flare Gas Combustion Monitoring

Monday, May 8, 2017 JOIN THE CONVERSATION Contact: Anthony Slapikas, (412) 826-2452, tony.slapikas@ametek.com AMETEK Develops FlarePro Mass Spectrometer for Flare Gas Combustion Monitoring Accurately and Reliably Determines Flare Gas Heating Values PITTSBURGH, PA—New rules for flare stack combustion from the US Environmental Protection Agency (EPA) set to take effect in early 2019 include additional monitoring and... Read more

May 3, 2017 Acad, Gov/Utilities M&A, Partnerships Materials Analysis

MTS Helps Esteemed Brazilian Research Institute Boost Operational Efficiency

EDEN PRAIRIE, MN, May 3, 2017 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test and measurement solutions, has completed the installation of the MTS Echo® remote lab monitoring technology in the Civil Engineering Structural and Materials Laboratory (www.lem.civ.puc-rio.br) at Rio de Janeiro’s Pontifícia Universidade Católica (PUC-Rio). The University deployed MTS... Read more

May 3, 2017 Acad, Gov/Utilities Clinical Research/Diagn. PR/Corporate

Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more

May 3, 2017 Acad, Gov/Utilities PR/Corporate

Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more

May 2, 2017 Acad, Gov/Utilities Licensing, IP, and Legal PR/Corporate

GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with coronary CT angiography

Chalfont St. Giles, UK, 2 May 2017 – Broadening its range of diagnostic options for clinicians and their patients, GE Healthcare announced today that it has received an indication approval from the U.S. Food and Drug Administration (FDA) for its imaging agent Visipaque™ (iodixanol) Injection. Visipaque 320 mg Iodine/mL is an iso-osmolar agent that is... Read more

April 24, 2017 Acad, Gov/Utilities M&A, Partnerships Materials Analysis Uncategorized

MTS Leading Edge Materials Testing Capabilities Drive Advances In U.S. Air Force's Aircraft Design

EDEN PRAIRIE, MN, April 24, 2017 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, has strengthened its global reputation as the industry leader in materials and structures testing for mission critical purposes. Through application of its comprehensive materials test technology, MTS is playing an integral part in... Read more

April 20, 2017 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Establishes Institute of Pathology at University Hospital Basel as Center of Excellence Partner

Thermo Fisher Scientific has signed an agreement with the Institute of Medical Genetics and Pathology at University Hospital Basel, Switzerland, to establish the leading institution as the first partner in the Next Generation Sequencing Companion Dx Center of Excellence Program, a new initiative designed to develop and refine Thermo Fisher’s NGS-based research assays from its... Read more